Tolerance to NeuroEPO in Parkinson Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel E Amaro Gonzalez, PhD Eng
Centro Inmunologia Molecular CIM Havana Cuba
Principal Investigator - Iliana Sosa Teste, PhD
Centro Nacional Producción Animales de Laboratorio (CENPALAB) Cuba
Principal Investigator - Teresita Rodríguez Obaya, PhD
Centro Immunologia Molecular CIM Havana Cuba
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Clinic of Movement Disorders, International Center for Neurological Restoration
Havana, Cuba
- Centro Inmunologia Molecular Cim
La Habana, Cuba
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Nov 2015
- Primary completion
- 11 Feb 2016
- Completion
- 1 Jan 2017
- Last update posted
- 15 Jul 2020
- Registered enrollment
- 26
- Registry id
- NCT04110678
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.